|
|
|
Insider
Information: |
Rennes Foundation |
Relationship: |
10% Owner |
City: |
Principality Of Liecheten |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
3,026,263 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,196,523 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
3,026,263 |
|
|
Total
Value |
$2,196,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ebix Inc |
EBIX |
10% Owner |
2019-08-19 |
2,915,981 |
2003-05-16 |
0 |
Premium* |
|
xBiotech Inc |
XBIT |
10% Owner |
2020-02-03 |
110,282 |
2018-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EBIX |
Ebix Inc |
10% Owner |
|
2015-05-22 |
4 |
B |
$37.35 |
$537,805 |
D/D |
14,400 |
3,746,473 |
2.45 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2017-03-07 |
4 |
D |
$58.50 |
$17,999,982 |
D/D |
(307,692) |
3,438,781 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2018-10-03 |
4 |
S |
$77.20 |
$988,160 |
D/D |
(12,800) |
3,425,981 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2018-12-06 |
4 |
S |
$46.00 |
$460,032 |
D/D |
(10,000) |
3,415,981 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2018-12-11 |
4 |
S |
$44.00 |
$8,800,000 |
D/D |
(200,000) |
3,215,981 |
0 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2018-12-21 |
4 |
B |
$6.24 |
$26,208 |
D/D |
4,200 |
3,590,182 |
2.37 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2018-12-27 |
4 |
B |
$4.98 |
$10,956 |
D/D |
2,200 |
3,592,382 |
2.37 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-01-02 |
4 |
B |
$5.15 |
$4,635 |
D/D |
900 |
3,593,282 |
2.37 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-02-06 |
4 |
B |
$8.93 |
$597,250 |
D/D |
65,000 |
3,658,282 |
2.45 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-02-07 |
4 |
B |
$10.00 |
$400,000 |
D/D |
40,000 |
3,698,282 |
2.45 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-02-27 |
4 |
B |
$8.13 |
$42,869 |
D/D |
5,273 |
3,853,555 |
2.37 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-02-28 |
4 |
B |
$8.19 |
$43,423 |
D/D |
5,302 |
3,858,857 |
2.37 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-03-01 |
4 |
B |
$8.13 |
$284,542 |
D/D |
34,999 |
3,893,856 |
2.45 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-03-04 |
4 |
B |
$7.91 |
$129,930 |
D/D |
16,426 |
3,910,282 |
2.45 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2019-06-04 |
4 |
B |
$8.25 |
$9,900,000 |
D/D |
1,200,000 |
5,110,282 |
2.45 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2019-08-13 |
4 |
S |
$38.04 |
$2,010,699 |
D/D |
(52,855) |
3,163,126 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2019-08-14 |
4 |
S |
$35.61 |
$3,561,030 |
D/D |
(100,000) |
3,063,126 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2019-08-15 |
4 |
S |
$34.41 |
$2,236,618 |
D/D |
(65,000) |
2,998,126 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2019-08-16 |
4 |
S |
$35.14 |
$2,111,493 |
D/D |
(60,000) |
2,938,126 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2019-08-19 |
4 |
S |
$30.20 |
$668,803 |
D/D |
(22,145) |
2,915,981 |
0 |
- |
|
XBIT |
xBiotech Inc |
10% Owner |
|
2020-02-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000,000 |
110,282 |
0 |
- |
|
EBIX |
Ebix Inc |
10% Owner |
|
2015-04-17 |
4/A |
B |
$28.35 |
$567,000 |
D/D |
20,000 |
3,715,473 |
2.45 |
- |
|
97 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|